Chromosome 1p and 11q Deletions and Outcome in NeuroblastomaEdward F. Attiyeh, John M. Maris|New England Journal of Medicine|2005Cited by 571
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous LeukemiaMohamed Bentires‐Alj, Benjamin G. Neel, J. Guillermo Paez et al.|Cancer Research|2004Cited by 512
Prevalence and functional consequence of PHOX2B mutations in neuroblastomaEric H. Raabe, John M. Maris, Mark L. Laudenslager et al.|Oncogene|2007Cited by 154
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial resultsKelly C. Goldsmith, Yaël P. Mossé, Bruce Pawel et al.|Nature Medicine|2023Cited by 125
The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor ModelsNathan M. Kendsersky, John M. Maris|Clinical Cancer Research|2021Cited by 119